| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |